SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-166765
Filing Date
2020-06-11
Accepted
2020-06-11 17:16:36
Documents
5
Effectiveness Date
2020-06-11

Document Format Files

Seq Description Document Type Size
1 S-8 d945135ds8.htm S-8 55149
2 EX-5.1 d945135dex51.htm EX-5.1 8407
3 EX-10.1 d945135dex101.htm EX-10.1 141600
4 EX-23.2 d945135dex232.htm EX-23.2 1872
5 GRAPHIC g945135capture.jpg GRAPHIC 10477
  Complete submission text file 0001193125-20-166765.txt   217239
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-239103 | Film No.: 20957977
SIC: 2834 Pharmaceutical Preparations